Nutrition awareness for women after non-metastatic breast cancer
Official title: Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Run by UNC Lineberger Comprehensive Cancer Center · NCT07389967 · Data updated 2026-11-12
This online program tests whether an educational brochure and short surveys can help women who have finished treatment for non-metastatic breast cancer recognize unhealthy processed foods and be willing to change their diet.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | January 20, 2026 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07389967 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women over 18 with a diagnosis of non-metastatic breast cancer who have completed primary treatment, have no recurrence or other active cancer, can read English, and can provide a private email address are ideal candidates.
✕Probably not a fit
People with metastatic or active recurrent cancer, those still undergoing primary treatment, non-English speakers, or those without reliable internet/email access are unlikely to benefit from this online educational protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-group, fully remote study enrolls women with non-metastatic breast cancer who have completed primary treatment and asks them to complete three online questionnaires delivered via REDCap. The first questionnaire collects sociodemographic data and a brief dietary recall, the second measures ability to identify ultra-processed foods, and participants then review a two-page educational flyer about diet, obesity, and cancer. The third questionnaire asks about willingness and ability to eat healthier and reduce unhealthy foods. All consent and study activities are completed by email and online surveys in English.
Why it matters
Potential benefit: If successful, the intervention could improve participants' ability to identify unhealthy processed foods and increase willingness to adopt dietary changes that may lower obesity-related risks.
How similar studies have gone: Prior survivorship and nutrition education studies have shown that education can improve knowledge and modest dietary behaviors, but targeted work on ultra-processed foods in non-metastatic breast cancer survivors is relatively limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 -Female * Diagnosis of non-metastatic breast cancer * Completion of primary treatment for breast cancer * No recurrence or metastasis; or no other cancer other than basal or squamous cell * Willingness to provide a private email address for all study activities * Ability to read and understand English Exclusion Criteria: * Inability to comply with one or more of the inclusion criteria
Where it's running
-
UNC Cancer Hospital
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Kirsten Nyrop, PhD — UNC Lineberger Comprehensive Cancer Center
- Study coordinator: Allison Ross
- Email: allison_ross@med.unc.edu
- Phone: 1 919-445-4905
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
First-line Sacituzumab Govitecan for Advanced Untreated Triple-Negative Breast Cancer
This study tests whether Sacituzumab Govitecan can slow disease progression when given as a first treatment to adults with advanced triple-negative breast cancer who have not yet received treatment in the advanced setting.
-
Radiology-based prediction of HER2 level and T‑DXd benefit in metastatic breast cancer
This study tests whether patterns in CT or FDG‑PET images can show HER2 level and help predict response to trastuzumab deruxtecan for people with metastatic breast cancer.
-
Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy
This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.
-
Imaging method for breast cancer using targeted PET scans
This study is testing a new type of PET scan that targets specific proteins in breast cancer to see if it can help doctors better identify and understand the disease.
-
Testing Abemaciclib with Radiation Therapy for Metastatic Breast Cancer
This study is testing different doses of the drug abemaciclib in people with metastatic breast cancer who are also getting hormone therapy and radiation to see if it helps them better manage their symptoms.
-
Combining TIL therapy and immunotherapy for advanced breast cancer
This study is testing a new treatment that combines a special type of immune cell therapy with a drug called Pembrolizumab to see if it can help people with advanced breast cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.